# Strata Critical Medical, Inc.: overview

SRTA · Nasdaq · CIK 1779128 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/srta.md) · [Financials](/companies/srta/financials.md) · [Filings](/companies/srta/filings.md) · [Insiders](/companies/srta/insiders.md)

Latest reported revenue: [$72.5m](/filings/0001628280-26-052256.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 4, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001628280-26-052256).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [36.1](/filings/0001628280-25-050870.md) | [36.4 d](/filings/0001628280-26-013628.md) | [35.9](/filings/0001628280-26-031032.md) | [45.1](/filings/0001628280-26-052256.md) | [49.3](/filings/0001628280-25-050870.md) | [66.8 d](/filings/0001628280-26-013628.md) | [67.4](/filings/0001628280-26-031032.md) | [72.5](/filings/0001628280-26-052256.md) |
| Gross margin | % | not reported | not reported | [19.6%](/filings/0001628280-26-031032.md) | [20.0%](/filings/0001628280-26-052256.md) | not reported | not reported | [21.0%](/filings/0001628280-26-031032.md) | [21.0%](/filings/0001628280-26-052256.md) |
| Operating margin | % | [(19.7%)](/filings/0001628280-25-050870.md) | [(16.2%) d](/filings/0001628280-26-013628.md) | [(15.8%)](/filings/0001628280-26-031032.md) | [(10.3%)](/filings/0001628280-26-052256.md) | [(11.4%)](/filings/0001628280-25-050870.md) | [(9.6%) d](/filings/0001628280-26-013628.md) | [(4.4%)](/filings/0001628280-26-031032.md) | [(7.5%)](/filings/0001628280-26-052256.md) |
| Net margin | % | [(5.4%)](/filings/0001628280-25-050870.md) | [(26.9%) d](/filings/0001628280-26-013628.md) | [(9.7%)](/filings/0001628280-26-031032.md) | [(8.3%)](/filings/0001628280-26-052256.md) | [116.5%](/filings/0001628280-25-050870.md) | [(13.2%) d](/filings/0001628280-26-013628.md) | [3.2%](/filings/0001628280-26-031032.md) | [(14.5%)](/filings/0001628280-26-052256.md) |
| Diluted EPS | $ per share | [(0.03)](/filings/0001628280-25-050870.md) | not reported | [(0.04)](/filings/0001628280-26-031032.md) | [(0.05)](/filings/0001628280-26-052256.md) | [0.70](/filings/0001628280-25-050870.md) | not reported | [0.03](/filings/0001628280-26-031032.md) | [(0.12)](/filings/0001628280-26-052256.md) |
| Free cash flow | $m | [(3.0) d](/filings/0001628280-25-050870.md) | [(6.3) d](/filings/0001628280-26-013628.md) | [(2.9)](/filings/0001628280-26-031032.md) | [(5.3) d](/filings/0001628280-26-052256.md) | [(40.2) d](/filings/0001628280-25-050870.md) | [(10.2) d](/filings/0001628280-26-013628.md) | [(1.3)](/filings/0001628280-26-031032.md) | [3.2 d](/filings/0001628280-26-052256.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Gross profit: us-gaap:GrossProfit. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-09-30) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [50.5](/filings/0001779128-23-000029.md) | [146](/filings/0001779128-24-000015.md) | [225](/filings/0001779128-25-000010.md) | [147](/filings/0001628280-26-013628.md) | [197](/filings/0001628280-26-013628.md) |
| Gross margin | % | not reported | not reported | not reported | [20.2%](/filings/0001628280-26-013628.md) | [20.9%](/filings/0001628280-26-013628.md) |
| Operating margin | % | [(47.7%)](/filings/0001779128-23-000029.md) | [(36.6%)](/filings/0001779128-24-000015.md) | [(30.3%)](/filings/0001779128-25-000010.md) | [(15.3%)](/filings/0001628280-26-013628.md) | [(11.3%)](/filings/0001628280-26-013628.md) |
| Net margin | % | [(79.3%)](/filings/0001779128-23-000029.md) | [(18.7%)](/filings/0001779128-24-000015.md) | [(24.9%)](/filings/0001779128-25-000010.md) | [(18.6%)](/filings/0001628280-26-013628.md) | [21.0%](/filings/0001628280-26-013628.md) |
| Diluted EPS | $ per share | [(0.93)](/filings/0001779128-23-000029.md) | [(0.38)](/filings/0001779128-24-000015.md) | [(0.76)](/filings/0001779128-25-000010.md) | [(0.35)](/filings/0001628280-26-013628.md) | [0.50](/filings/0001628280-26-013628.md) |
| Free cash flow | $m | [(15.9)](/filings/0001779128-23-000029.md) | [(37.9)](/filings/0001779128-24-000015.md) | [(34.5)](/filings/0001779128-25-000010.md) | [(33.4)](/filings/0001628280-26-013628.md) | [(58.5)](/filings/0001628280-26-013628.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Gross profit: us-gaap:GrossProfit.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/srta/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Third Point LLC](/funds/1040273.md) | 2026-06-30 | $26.4m | 5,000,000 |  | Unchanged |
| [Northern Right Capital Management, L.P.](/funds/1346543.md) | 2026-06-30 | $25.8m | 4,890,584 |  | Added +800,415 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $25.5m | 4,835,516 |  | Added +267,248 |
| [ROYCE & ASSOCIATES LP](/funds/906304.md) | 2026-06-30 | $16.5m | 3,132,933 |  | Added +316,561 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $15.2m | 2,885,319 |  | Added +12,873 |
| [AWM Investment Company, Inc.](/funds/1535264.md) | 2026-06-30 | $14.9m | 2,821,468 |  | Unchanged |
| [ARK Investment Management LLC](/funds/1697748.md) | 2026-06-30 | $14.4m | 2,730,855 |  | Reduced −4,724,429 |
| [First Eagle Investment Management, LLC](/funds/1325447.md) | 2026-06-30 | $12.2m | 2,314,614 |  | Added +48,371 |
| [First Eagle Investment Management, LLC](/funds/1325447.md) | 2026-06-30 | $12.2m | 2,314,614 |  | Added +48,371 |
| [Pillsbury Lake Capital LLC](/funds/2111915.md) | 2026-06-30 | $11.4m | 2,171,006 |  | Reduced −432,790 |

## Recent filings

[All 565 filings](/companies/srta/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-15 | 16:09 ET | [SCHEDULE 13D](/filings/0000899140-26-001108.md) | Ownership report, active investor | 0000899140-26-001108 |
| 2026-08-04 | 11:35 ET | [10-Q](/filings/0001628280-26-052256.md) | Quarterly report, period 2026-06-30 | 0001628280-26-052256 |
| 2026-08-04 | 07:13 ET | [8-K](/filings/0001628280-26-052152.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-052152 |
| 2026-06-03 | 16:25 ET | [8-K](/filings/0001628280-26-040342.md) | 5.07 Shareholder vote results | 0001628280-26-040342 |
| 2026-05-08 | 16:50 ET | [SCHEDULE 13D/A](/filings/0002126691-26-000005.md) | Ownership report, active investor, amended | 0002126691-26-000005 |
| 2026-05-06 | 11:53 ET | [10-Q](/filings/0001628280-26-031032.md) | Quarterly report, period 2026-03-31 | 0001628280-26-031032 |
| 2026-05-06 | 07:09 ET | [8-K](/filings/0001628280-26-030898.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-030898 |
| 2026-04-16 | 17:31 ET | [SCHEDULE 13D/A](/filings/0002126691-26-000003.md) | Ownership report, active investor, amended | 0002126691-26-000003 |
| 2026-04-14 | 08:54 ET | [DEF 14A](/filings/0001140361-26-014530.md) | Proxy statement, period 2026-05-28 | 0001140361-26-014530 |
| 2026-04-08 | 17:03 ET | [SCHEDULE 13D/A](/filings/0002126691-26-000002.md) | Ownership report, active investor, amended | 0002126691-26-000002 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-013628.md), filed Mar 3, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/9a8fdbf7-362c-4f47-8f62-fb9efcd3131b)

## About the filer

- CIK: 1779128
- Tickers: SRTA
- Exchange: Nasdaq
- SIC code: 4700 Transportation Services
- State of incorporation: DE
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 16:13 ET. No prices; not investment advice.